Myriad Genetics Inc (MYGN)
Receivables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 837,600 | 753,200 | 678,400 | 690,600 | 557,000 |
| Receivables | US$ in thousands | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue ÷ Receivables
= $837,600K ÷ $—K
= —
The receivables turnover ratio for Myriad Genetics Inc is not available for the years ending December 31, 2020, 2021, 2022, 2023, and 2024 based on the provided data. The receivables turnover ratio is a measure of how effectively a company is managing its accounts receivable by analyzing how many times during a period the company collects its average accounts receivable balance.
In the absence of specific data for this ratio, it is challenging to assess the company's efficiency in collecting receivables. A high receivables turnover ratio typically indicates that the company is efficient in collecting payments from customers, while a low ratio may suggest potential issues with credit policies or difficulties in collecting payments on time. It is important for Myriad Genetics Inc to monitor and analyze this ratio over time to ensure optimal management of its accounts receivable and overall financial health.
Peer comparison
Dec 31, 2024